Rheumatoid arthritis isn’t currently curable. But treatments can help manage symptoms, improve quality of life, support movement, and slow disease progression. Speak to a doctor about which ...

Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism.

Although their primary role in the pathology of this disease is disputed ... activation and cartilage degradation in rheumatoid arthritis. Testing hypotheses reliably in pre-clinical studies ...

Rheumatoid arthritis is an autoimmune disease that is characterized by inflammation of the joints and the subsequent destruction of cartilage and erosion of the bone. Patients with rheumatoid ...

Lung-related conditions and symptoms associated with rheumatoid arthritis (RA) include interstitial lung disease, lung nodules, and small airway obstruction. Rheumatoid arthritis (RA) is an ...

Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...

Rheumatoid arthritis (RA) is a type of autoimmune disease in which your body attacks healthy joint tissue. Common symptoms of RA include morning stiffness and joint pain, typically in the same ...

This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

Rheumatoid arthritis (RA) is a prototype immune-mediated inflammatory disease, characterised by a symmetric polyarthritis usually involving the small joints of the hands and feet. Other joints can ...

Rheumatoid arthritis (RA) is an autoimmune and inflammatory disease, where the immune system attacks healthy cells in the ...

Talk to your doctor about joining either an in-person support group near your home or an online forum, such as one of the Arthritis Foundation’s Connect Groups or CreakyJoints, a free online ...

Each year, clinical upper gastrointestinal events occur in 2 to 4 percent of patients who are taking nonselective nonsteroidal antiinflammatory drugs (NSAIDs). We assessed whether rofecoxib, a ...